Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China
· Delayed Price · Currency is CNY 64.05
+2.05 (3.31%)
Mar 10, 2026, 3:00 PM CST
SHA:688621 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 6,999 | 6,792 | 4,222 | 7,812 | 8,192 | 9,728 | Upgrade
|
| Market Cap Growth | 67.54% | 60.85% | -45.95% | -4.64% | -15.79% | - | Upgrade
|
| Enterprise Value | 6,884 | 6,677 | 4,027 | 7,561 | 7,889 | 9,536 | Upgrade
|
| Last Close Price | 64.05 | 62.15 | 37.59 | 69.26 | 72.13 | 85.40 | Upgrade
|
| PE Ratio | 35.78 | 34.64 | 23.80 | 42.28 | 52.35 | 92.07 | Upgrade
|
| Forward PE | - | 31.74 | 31.74 | 31.74 | 41.58 | 79.34 | Upgrade
|
| PS Ratio | 5.75 | 5.58 | 3.92 | 8.38 | 12.11 | 19.71 | Upgrade
|
| PB Ratio | 6.01 | 5.83 | 3.83 | 7.39 | 9.02 | 12.64 | Upgrade
|
| P/TBV Ratio | 6.19 | 6.00 | 3.95 | 7.75 | 9.45 | 13.28 | Upgrade
|
| P/FCF Ratio | - | - | 2749.41 | 392.53 | 89126.79 | 2953.42 | Upgrade
|
| P/OCF Ratio | - | - | 131.87 | 84.13 | 78.80 | 110.23 | Upgrade
|
| EV/Sales Ratio | 5.65 | 5.48 | 3.73 | 8.11 | 11.66 | 19.32 | Upgrade
|
| EV/EBITDA Ratio | 29.99 | 28.87 | 19.96 | 35.09 | 45.56 | 72.53 | Upgrade
|
| EV/EBIT Ratio | 33.71 | 32.70 | 22.84 | 39.08 | 50.53 | 79.49 | Upgrade
|
| EV/FCF Ratio | - | - | 2621.91 | 379.91 | 85835.42 | 2895.08 | Upgrade
|
| Debt / Equity Ratio | 0.51 | 0.51 | 0.41 | 0.42 | 0.28 | 0.27 | Upgrade
|
| Debt / EBITDA Ratio | 2.54 | 2.54 | 2.03 | 1.88 | 1.32 | 1.40 | Upgrade
|
| Debt / FCF Ratio | - | - | 296.79 | 22.44 | 2802.12 | 62.76 | Upgrade
|
| Net Debt / Equity Ratio | -0.10 | -0.10 | -0.14 | -0.26 | -0.40 | -0.57 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.51 | -0.51 | -0.79 | -1.27 | -2.10 | -3.36 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -104.03 | -13.78 | -3965.47 | -133.93 | Upgrade
|
| Asset Turnover | - | - | 0.56 | 0.56 | 0.50 | 0.61 | Upgrade
|
| Inventory Turnover | - | - | 36.48 | 29.97 | 29.56 | 32.55 | Upgrade
|
| Quick Ratio | - | - | 1.80 | 1.69 | 1.93 | 2.15 | Upgrade
|
| Current Ratio | - | - | 1.95 | 1.78 | 2.01 | 2.25 | Upgrade
|
| Return on Equity (ROE) | 17.29% | 17.29% | 15.65% | 18.61% | 18.91% | 22.61% | Upgrade
|
| Return on Assets (ROA) | - | - | 5.72% | 7.27% | 7.21% | 9.21% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.01% | 20.01% | 19.62% | 27.57% | 33.58% | 49.08% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 14.60% | 17.60% | 16.50% | 14.50% | Upgrade
|
| Earnings Yield | 2.80% | 2.89% | 4.20% | 2.37% | 1.91% | 1.09% | Upgrade
|
| FCF Yield | - | - | 0.04% | 0.26% | 0.00% | 0.03% | Upgrade
|
| Dividend Yield | 0.26% | - | 0.43% | 0.24% | 0.59% | 0.22% | Upgrade
|
| Payout Ratio | - | - | 21.51% | 30.05% | 17.24% | 1.18% | Upgrade
|
| Buyback Yield / Dilution | 2.44% | 2.44% | -0.28% | -0.19% | -14.09% | -16.84% | Upgrade
|
| Total Shareholder Return | 2.70% | 2.44% | 0.16% | 0.05% | -13.50% | -16.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.